ASC News Archives - Page 414 of 1382

3 healthcare companies named on Forbes' biggest layoffs of 2022 list

Three healthcare companies have been named on Forbes' list of the 64 biggest company layoffs in 2022:

4 ASC acquisitions, partnerships

Here are three acquisitions and partnerships involving ASCs that Becker's has reported on since Sept. 12:

Most-recruited physician specialties for the last 5 years

Family medicine is the most-recruited physician specialty in 2022, according to Merritt Hawkins and AMN Healthcare's "Review of Physician and Advanced Practitioner Recruiting Incentives."

6 physician fraud cases in September

Here are six physician healthcare fraud cases since Sept. 1:

Cost of COVID-19 screening in 21 states in September

COVID-19 screenings were the most expensive in Maine in September, according to an Oct. 4 U.S. Health Care Price Index report from healthcare marketplace Sesame.

Google takes another step into the ASC, hospital space with medical imaging suite

Google has released its Medical Imaging Suite, an AI tool allowing medical organizations to read, store and label medical imaging, Forbes reported on Oct. 4.

Companies surpass September expectations, add 208,000 jobs

The U.S. labor market added 208,000 jobs in September, surpassing the Dow Jones' estimated 200,000 jobs, CNBC reported Oct. 5.

FDA's tendency to issue drug safety alerts on Fridays harmful to public health, study finds

The U.S. Food and Drug Administration is most likely to release drug safety alerts on Friday, the day of the week when most people pay less attention to the news, according to an Oct. 4 report from Medscape.

Georgia physician, pharmacist plead guilty to pill mill operation

Atlanta-based former gynecologist Anthony Mills and pharmacist Raphael Ogunsusi have pleaded guilty for their roles in operating a "pill mill" network, the U.S. Justice Department said Oct. 4.

Boston, San Francisco remain among top life science clusters, report says

The top life science clusters in the U.S. remain Boston, San Francisco, San Diego and Raleigh/Durham, N.C., according to the "2022 Mid-Year Life Science Overview and Market Clusters" report by commercial real estate advisory firm Newmark.